Literature DB >> 26772875

Outcomes of Air Injection Within 2 mm Inside a Deep Trephination for Deep Anterior Lamellar Keratoplasty in Eyes With Keratoconus.

Massimo Busin1, Vincenzo Scorcia2, Pia Leon3, Yoav Nahum4.   

Abstract

PURPOSE: To evaluate the outcomes of a new technique for deep anterior lamellar keratoplasty (DALK) employing the injection of air up to 2 mm inside a deep trephination (intended within 100 μm from the endothelial surface) obtained with a guarded trephine set by means of anterior segment optical coherence tomography (AS OCT).
DESIGN: Retrospective, noncomparative, interventional case series.
METHODS: The success rate and learning curve of pneumatic dissection in one clinical practice were analyzed in nonscarred keratoconic eyes undergoing a standardized DALK including 9-mm trephination intended to a depth within 100 μm from the endothelial surface, based on the thinnest AS OCT measurement at this site; and injection of air through a cannula advanced 1-2 mm centripetally from the bottom of the trephination. Surgical parameters, success rate of pneumatic dissection, and complications were recorded.
RESULTS: Eighty-eight eyes of 88 patients were included in the study. Pneumatic dissection succeeded in 75 of 88 eyes (85%). No significant correlation could be found between number of cases performed and success rate for this surgeon. Complications included loss of suction during trephination (n = 2, 2.3%) and perforation (n = 4, 4.6%). Conversion to penetrating keratoplasty was necessary in 1 case (1.1%).
CONCLUSION: Setting an adjustable trephine to a depth within 100 μm from the endothelial surface eliminates the need for reaching the central cornea for successful pneumatic dissection and substantially flattens the learning curve of DALK, while achieving a constant success rate above 80% and minimizing complications.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26772875     DOI: 10.1016/j.ajo.2015.12.033

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Weighing of risk factors for penetrating keratoplasty graft failure: application of Risk Score System.

Authors:  Abdo Karim Tourkmani; Valeria Sánchez-Huerta; Guillermo De Wit; Jaime D Martínez; David Mingo; Ignacio Mahillo-Fernández; Ignacio Jiménez-Alfaro
Journal:  Int J Ophthalmol       Date:  2017-03-18       Impact factor: 1.779

2.  Deep anterior lamellar keratoplasty for keratoconus: Elements for success.

Authors:  Marco Pellegrini; Angeli Christy Yu; Massimo Busin
Journal:  Saudi J Ophthalmol       Date:  2022-07-11

3.  Preliminary Results of a Novel Standardized Technique of Femtosecond Laser-Assisted Deep Anterior Lamellar Keratoplasty for Keratoconus.

Authors:  Andrea Lucisano; Giuseppe Giannaccare; Marco Pellegrini; Federico Bernabei; Angeli Christy Yu; Adriano Carnevali; Laura Logozzo; Giovanna Carnovale Scalzo; Vincenzo Scorcia
Journal:  J Ophthalmol       Date:  2020-09-03       Impact factor: 1.909

4.  Needle Depth and Big-Bubble Success in Deep Anterior Lamellar Keratoplasty: An Ex Vivo Microscope-Integrated OCT Study.

Authors:  Neel D Pasricha; Christine Shieh; Oscar M Carrasco-Zevallos; Brenton Keller; David Cunefare; Jodhbir S Mehta; Sina Farsiu; Joseph A Izatt; Cynthia A Toth; Anthony N Kuo
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

5.  Optical Coherence Tomography Guided Robotic Needle Insertion for Deep Anterior Lamellar Keratoplasty.

Authors:  Mark Draelos; Gao Tang; Brenton Keller; Anthony Kuo; Kris Hauser; Joseph A Izatt
Journal:  IEEE Trans Biomed Eng       Date:  2019-11-20       Impact factor: 4.538

6.  One-Year Outcome Predictors of Strabismus Surgery from Anterior Segment Optical Coherence Tomography with Multiple B-Scan Averaging.

Authors:  Manabu Miyata; Kenji Suda; Akihito Uji; Masayuki Hata; Akio Oishi; Eri Nakano; Akinari Yamamoto; Shinya Nakao; Hiroshi Ohtsuki; Akitaka Tsujikawa
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.